Brexpiprazole provides new second-line treatment options for patients with major depressive disorder
Brexpiprazole, an antipsychotic drug approved this summer by the U.S. Food and Drug Administration, is an effective and well-tolerated addition to conventional first-line antidepressants for the treatment of major depressive ...
Aug 27, 2015
0
17